This grant supports clinically relevant research aimed at accelerating the translation of immunological discoveries into cancer therapies specifically for chordoma. It funds projects that bridge laboratory and clinical research to advance immunotherapies targeting this rare cancer.
Eligibility criteria are not provided for this funding opportunity.
